Top 10 Managed Healthcare Companies To Invest In Right Now

NEW YORK (TheStreet) –Sprint (S) rose 3% on Thursday to $9.95 based on continued reports of a possible merger with competitor T-Mobile (TMUS). Shares of T-Mobile rose 2.3% to $32.95 on the reports.

Japanese carrier Softbank, which currently owns Sprint, is reportedly looking to buy T-Mobile from Deutsche Telekom sometime in the first half of 2014. Softbank would then merge Sprint and T-Mobile, cutting the number of U.S. mobile carriers to three from four. The combined carrier would compete with Verizon (VZ) and AT&T (T), the two largest carriers in the U.S.

Softbank may face some competition from Dish (DISH), which is also reportedly exploring an acquisition of T-Mobile.

S data by YCharts

Top 10 Managed Healthcare Companies To Invest In Right Now: EnerNOC Inc (ENOC)

EnerNOC, Inc. (EnerNOC), incorporated on June 5, 2003, is a provider of energy management applications, services and products for the smart grid, which include demand response, data-driven energy efficiency, and energy price and risk management applications, services and products. The Company’s energy management applications, services and products enable energy management strategies for commercial, institutional and industrial end-users of energy, which it refers to as its C&I customers, and its electric power grid operator and utility customers by reducing real-time demand for electricity, increasing energy efficiency and improving energy supply transparency. The Company’s energy management applications, services and products include its EnerNOC EfficiencySMART and SupplySMART applications and services, and certain wireless energy management products.


The Company’s demand response capacity provides an alternative to building co nventional supply-side resources, such as natural gas-fired peaking power plants, to meet periods of peak electricity demand. The Company is in the development, implementation and broader adoption of technology-enabled demand response services for the smart grid. The Company’s DemandSMART application enables us to send control signals to, and receive bi-directional communications from, an Internet-enabled network of dispersed C&I customer sites in order to initiate, monitor and complete demand response activity. The Company’s technology and operational processes have the ability to automate demand response and simplify C&I customer participation by remotely reducing electricity usage in a matter of minutes, or send curtailment instructions to its C&I customers to be manually implemented on site. The devices that it installs at its C&I customer sites transmit to us through the cellular network and Internet near real-time electrical consumption data on a 1-minute, 5-minute , 15-minute or hourly basis. The Company’s DemandSMART app! lication analyzes the data from individual sites and aggregates data for specific regions. When a demand response event occurs, its network operations center (NOC) automatically processes the notification coming from the electric power grid operator or utility. The Company’s NOC operators then begin activating procedures to curtail demand from the grid at its C&I customer sites.

The Company provides its demand response services to electric power grid operators and utilities under long-term contracts and pursuant to open market bidding programs. The Company’s long-term contracts generally have terms of 3-10 years and predetermined capacity commitment and payment levels. Within these contracts and open market programs, it offers the services to address the needs of electric power grid operators and utilities: reliability-based demand response, price-based demand response, and short-term reserve resources referred to in the electric power industry as ancillary services.


EfficiencySMART is the Company’s data-driven energy efficiency suite that includes energy efficiency planning, audits, assessments, commissioning and retro-commissioning authority services, and a cloud-based energy analytics application used for managing energy across a C&I customer’s portfolio of sites. The cloud-based energy analytics application also includes the ability to integrate with a C&I customer’s existing energy management system, provide utility bill management and tools for measurement, tracking, analysis, reporting and management of greenhouse gas emissions. The Company offers the EfficiencySMART applications and services, which include EfficiencySMART Plan, EfficiencySMART Audit, EfficiencySMART Assessment, EfficiencySMART Commissioning and EfficiencySMART Insight.

EfficiencySMART Plan provides its C&I customers with a multi-year profile of projected energy demand, consumption and costs, including a lifecycle financial analysis of potential energy! strategi! es and a roadmap for implementation. EfficiencySMART Audit provides its C&I customers with energy efficiency recommendations in compliance with the American Society of Heating, Refrigeration and Air-Conditioning (ASHRAE) standards for conditioned space, and tactical energy surveys for industrial facilities. EfficiencySMART Assessment provides detailed recommendations for energy savings, demand reductions, reductions in energy intensity through operation and maintenance activities, equipment retrofits, behavioral changes, or the use of new technologies. EfficiencySMART Commissioning includes traditional and/or new building commissioning services, such as investigation, testing and verification of energy efficiency strategies, and data analytics over a specified period of time. EfficiencySMART Insight provides its large, multi-site C&I customers with a Software-as-a-Service enterprise energy management solution that provides persistent commissioning with the ability to visuali ze near real-time energy usage, identify savings opportunities, and prioritize energy-related investments across a portfolio of meters and buildings across a C&I customer’s organization.


SupplySMART is the Company’s energy price and risk management application that provides its C&I customers located in restructured or deregulated markets throughout the United States with the ability to more effectively manage the energy supplier selection process, including energy supply product procurement and implementation. SupplySMART provides a framework for developing and implementing risk management strategies and executing purchasing strategies that provides maximum price transparency and structural savings on an ongoing basis for its C&I customers.

Technology and Operations

The Company’s technology has been developed provides a platform on which to design, customize, and implement its energy management application s, services and products. The Company’s technology infrast! ructure i! s built on Linux, Java and Oracle, and supports open Web services architecture. The Company’s enterprise energy management application platform enables the Company to efficiently scale its DemandSMART, EfficiencySMART, and SupplySMART applications and services, as well as certain wireless energy management products, in new geographic regions and rapidly grow the number of C&I customers in its network. The Company’s energy management application platform leverages Web services and wireless technologies that connect applications directly with other applications through a form of loose coupling, which allows connections to be established across applications without customization.

Network Operations Center

The Company’s technology enables its NOC to automatically respond to signals sent by electric power grid operators and utilities to deliver demand reductions within targeted geographic regions. The Company can customize its technology to receiv e and interpret many types of dispatch signals sent directly from an electric power grid operator or utility customer to its NOC. Following the receipt of such a signal, its NOC automatically notifies specified C&I customer personnel of the demand response event. After relaying this notification to its C&I customers, it initiate processes that reduce their electricity consumption from the electric power grid. These processes may include dimming lights, shifting equipment to power save mode, adjusting heating and cooling set points and activating a back-up generator. Demand reduction is monitored remotely with near real-time data feeds, the results of which are displayed in its NOC through various data presentment screens.

Energy Management Platform

The Company’s energy management platform is consists of its cloud-based enterprise software platform used for DemandSMART, EfficiencySMART and SupplySMART, as well as wireless energy management products and technology, and is the underlying system that runs its ! NOC. It u! tilizes a modular Web services architecture that is designed to allow application modules to be easily integrated into the platform. The Company use its energy management platform to measure, manage, benchmark and optimize C&I customers’ energy consumption and facility operations. The Company use this data to help C&I customers analyze consumption patterns, forecast demand, measure real-time performance during demand response events, continuously monitor building management equipment to optimize system operation, model rates and tariffs and create energy scorecards to benchmark similar facilities. In addition, its energy management application platform has the ability to track its C&I customers’ greenhouse gas emissions by mapping their energy consumption with the fuel mix used for generation in their location, such as the proportion of coal, nuclear, natural gas, fuel oil and other sources used.

The EnerNOC Site Server

The Company designs and installs a small device, called an EnerNOC Site Server, or ESS, at each C&I customer site to collect and communicate to its platform near real-time electricity consumption data and, in certain cases, enable remote control of a C&I customer’s electricity consumption. The ESS communicates to its NOC through the C&I customer’s LAN or secure Internet connection. The ESS is an open, integrated system consisting of a central hardware device residing inside a standard electrical box. The ESS allows its C&I customers to, among other things, respond quickly and completely to instructions from us to reduce electricity consumption. The Company also supports OpenADR protocol on its most recent ESS devices, an emerging standard for automated demand response communications.

The Company competes with Comverge, Inc., Exelon Corporation, Energy Curtailment Specialists and Hess, Inc., as well as energy technology providers Lucid Design Group, Inc., Building IQ, SCIEnergy, Inc . and McKinstry Co., LLC.

Advisors’ Opinion:

  • [By John Udovich]

    Small cap cloud stock Opower Inc (NYSE: OPWR), a cloud solutions provider to the utility sector, IPO’d at $19 on Friday to close at $23 a share, meaning its worth taking a closer look at the stock plus take a look at the performance of smart meter or smart grid stocks like Itron, Inc (NASDAQ: ITRI), Echelon Corporation (NASDAQ: ELON) and EnerNOC, Inc (NASDAQ: ENOC).

  • [By Damian Illia]

    Finally, I always like to see one of the most important financial ratios applying to stockholders, the best measure of performance for a firm’s management: the return on equity. The ratio has decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness. Moreover, it is worse than those shown in the table like Aegion Corporation (AEGN), EnerNOC Inc. (ENOC), MYR GroupInc. (MYRG) and Pike Corporation (PIKE).

  • [By Rich Smith]

    Boston, Mass.-based EnerNOC (NASDAQ: ENOC  ) has a new chief financial officer.

    On Tuesday, the energy “smartgrid” software maker announced that it has hired Neil Moses, until March the chief global strategy officer for Dunkin’ Brands (NASDAQ: DNKN  )  and onetime CFO, as its new CFO.

Top 10 Managed Healthcare Companies To Invest In Right Now: E*TRADE Financial Corporation(ETFC)

E*TRADE Financial Corporation, a financial services company, provides online brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand in the United States. It offers trading products and services, including automated order placement and execution of the U.S. equities, futures, options, exchange-traded funds, and bond orders; sweep deposit accounts; access to E*TRADE Mobile Pro to trade stocks and transfer funds between accounts, as well as to monitor real-time investment, market, and account information; access to Power E*TRADE Pro, a desktop trading software for active traders; an open applications programming interface for third-party and independent software developers; margin accounts; cross boarder trading; access to international equities; research and trade idea generation tools; and E*TRADE Community that utilizes social media to offer a platform to customers. The company also provides access to the inve stor resource center that provides an aggregated view of its investing tools, market insights, independent research, education, and other investing resources; advisory services through Online Advisor; fixed income tools to identify, evaluate, and implement fixed income investment strategies; access to Retirement QuickPlan calculator that provides action plan on personal retirement savings; one-on-one portfolio recommendations and personalized plans; managed investment portfolio advisory services; unified managed account advisory services; individual retirement accounts; access to non-proprietary exchange-traded funds and mutual funds; investing and trading educational services through online videos, Web seminars, and Web tutorials; and deposit accounts, including checking, savings, and money market accounts. In addition, it provides software and services for managing equity compensation plans for corporate customers. The company was founded in 1982 and is headquartered in N e w York, New York.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of E*Trade Financial (ETFC) have fallen today following a report that Finra is looking into whether customers got the best fills on its G1 Execution service.

    Getty Images

    Sandler O’Neill’s Richard Repetto and Mike Adams do not believe the Finra investigation of E*Trade Financial “is new news.” They explain why:

    While the NY Post article on ETFC’s order routing practices implies a FINRA investigation is new (disclosed in recently filed 2013 10-K), we do not believe it is new news at all. First, ETFC disclosed that FINRA initiated an investigation on July 11, 2013 both in its 2Q13 10-Q (filed August 6, 2013) and 3Q13 10-Q (filed November 7, 2013). Even the recent disclosure in the 2013 10-K was filed 2 months ago on February 25, 2014.

    Shares of E*Trade Financial have fallen 3.1% to $21.69 at 3:05 p.m.–and it’s not the only online broker getting hit today. Charles Schwab (SCHW) has declined 2.1% to $26.29, while TD Ameritrade (AMTD) has dropped 2.5% to $31.66 despite getting an upgrade from Bernstein Research. Interactive Brokers (IBKR), however, has gained 0.3% to $23.77.

    Bernstein’s Brad Hintz and team explain why they upgraded TD Ameritrade:

    The evidence that the retail investor has returned to the markets has become undisputable. The most recent confirmation was TD Ameritrade’s strong Q1 2014 earnings report last week. The client trading and engagement statistics were compelling, as were those at Schwab in its Q1 earnings the week before. But valuation on AMTD has been the countervailing factor. The stock was the best performer in our coverage group in 2013, and has maintained a 20+ forward P/E multiple for almost a year. However, the recent HFT-related pullback, thanks to Michael Lewis’s Flash Boys, combined with accelerating retail activity, provides an entry window. The HFT pullback is overdone, and the risk related to payment for order flow (PFOF) is limite

  • [By victorselva]

    The Charles Schwab Corporation (SCHW) is a savings and loan holding company. The company is engaged, through its subsidiaries, in securities brokerage, banking, money management, and financial advisory services. Its subsidiaries include Charles Schwab & Co. (a leading discount broker-dealer), Charles Schwab Investment Management (a mutual fund investment advisor) and Charles Schwab Bank.In this article, let’s take a look at this brokerage firm and try to explain to investors the reasons this is an apparently appealing investment opportunity.The FocusThe company provides financial services to individuals and institutional clients through two segments: Investor Services and Institutional Services. The Investor Services segment provides retail brokerage and banking services to individual investors. The Institutional Services segment provides custodial, trading, and support services to independent investment advisors. The Institutional Services segment also provides retir ement plan services, specialty brokerage services, and mutual fund clearing services. The company seeks to meet the financial services needs of investors, advisers and employers. It focuses on building client loyalty with the goal of attracting new clients and serving them. Additionally, Schwab´s strengths through shared core processes and technology advances which help create services that are scalable and consistent with the business.Interest Rates, Capital Structure and Debt-to-Capital RatioThe results are dependent on short-term interest rates, as 37% of its top line came from net interest income in the first quarter of 2014.The broker has been making significant efforts to become less dependent on interest rates, which we expect Federal Reserve will raise them in late 2014 or 2015. Also, the company´s plan is to reach a low-cost capital structure and targets a long-term debt-to-total financial capital ratio of less than 30%.Lucrative Derivatives Trading In 2011, the c ompany acquired Compl

  • [By Ben Levisohn]

    Only the Nasdaq Composite showed the true destruction: It fell 2.6% to 4,127.73 on Friday and finished off 0.7% on the week. Among the big losers: E*Trade Financial (ETFC), which plunged 9.6% to $20.43 on concerns about its “pay for order flow” practices, Akamai Technologies (AKAM), which fell 6.7% to $54.35, Netflix (NFLX), which dropped 6% to $337.31 despite the fact that it might get a boost from Amazon’s (AMZN) new set-top box. Regeneron Pharmaceuticals (REGN) dropped 4.9% to $285.34 as biotech stocks got drubbed.

Top 10 Managed Healthcare Companies To Invest In Right Now: TESARO Inc (TSRO)

TESARO, Inc. (TESARO), incorporated in March 2010, is a development-stage, oncology-focused biopharmaceutical company for cancer patients. The Company focuses on rolapitant and TSR-011 product. The Company’s marketed products and product candidates in development treat cancer through non-specific damage to cellular components or alter cell metabolism or internal repair mechanisms to the demise of cancer cells.


Rolapitant is a potent and long-acting neurokinin-1, or NK-1, receptor antagonist is in Phase III clinical trials for the prevention of chemotherapy induced nausea and vomiting (CINV). It is in Phase III clinical trials. CINV, if not prevented by prophylaxis, has the potential to afflict up to 90% or more of cancer patients undergoing chemotherapy, depending upon the type of chemotherapy administered the dosing schedule of the chemotherapy, and the patients’ age and gender, among other predisposing factors. Prolonged nausea an d vomiting may result in unwanted weight loss, dehydration and malnutrition, as well as hospitalization. The Company has in-licensed the rights to rolapitant from OPKO Health, Inc.


TSR-011 is an orally available ALK inhibitor in preclinical development. ALK is known to be involved in certain types of cancers, including subsets of NSCLC, neuroblastoma and lymphoma. For patients in these subsets, the ALK gene is fused to an activating partner or contains point mutations, resulting in constitutive activation of ALK and the growth of cancer cells and tumor development. Inhibition of ALK in these cancer cells results in cell death and tumor growth inhibition or regression. In August 2011, the United States Food and Drug Administration approved the first ALK inhibitor, developed by Pfizer Inc., Xalkori (crizotinib), which was approved for the treatment of patients with locally advanced or metastatic NSCLC that are ALK positive.

The Company competes with GlaxoSmithKline plc, Roche Holding Ltd! . and Sanofi S.A.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Werber and Eckhard’s favorites include Gilead (GILD) and Celgene (CELG), and they find the “risk/reward…compelling” in Medivation (MDVN) and Tesaro (TSRO).

  • [By Brian Orelli]

    Tesaro (NASDAQ: TSRO  ) is also up today after announcing that it established a partnership with clinicians to run the phase 3 development of its PARP inhibitor, niraparib. The trial will enroll about 300 breast cancer patients with BRCA mutations, comparing niraparib to investigators’ choice of other breast cancer treatments.

  • [By Keith Speights]

    Positive response
    Clovis wasn’t the only company to bring good news about an ovarian cancer drug to ASCO. TESARO  (NASDAQ: TSRO  ) announced phase 1 results for niraparib. Shares of the biotech jumped 16% for the week.

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, biopharmaceutical company TESARO (NASDAQ: TSRO  ) has received the dreaded one-star ranking.

Top 10 Managed Healthcare Companies To Invest In Right Now: Boston Properties Inc. (BXP)

Boston Properties, Inc., a real estate investment trust (REIT), together with its subsidiaries, engages in the ownership and development of office properties. Its properties are located in Boston, Massachusetts; Washington, D.C.; midtown Manhattan, New York; San Francisco, California; and Princeton, New Jersey. As of December 31, 2008, the company owned interests in 147 properties, totaling approximately 49.8 million net rentable square feet and structured parking for vehicles containing approximately 11.2 million square feet. Its properties also included 143 office properties, 1 hotel, and 3 retail properties. In addition, the company owned or controlled an undeveloped land totaling approximately 509.3 acres. Boston Properties, Inc. has elected to be taxed as REIT under the Internal Revenue Code and would not be subject to federal income taxes, if it distributes approximately at least 90% of its taxable income to its shareholders. The company was founded in 1970 and is ba sed in Boston, Massachusetts.

Advisors’ Opinion:

  • [By Dimitra DeFotis]

    Among real estate trusts:

    American Tower  (AMT), the diversified  REIT, is the best performer in the index. It was up 4.6% after saying Friday it will buy the parent of tower operator Global Tower Partners for $4.8 billion. HCP (HCP), a healthcare REIT, was up 3.3%. Prologis (PLD) an industrial REIT, was up 2.8%. Vornado Realty Trust (VNO) was up 2.7%. Boston Properties (BXP), the office REIT, was up 2.3%. Equity Residential (EQR), a residential REIT, was up 2.4%. Ventas (VTR), a healthcare REIT, was up 2%.


  • [By Markus Aarnio]

    Owens Realty Mortgage’s competitors include American Assets Trust (AAT), Alexandria Real Estate Equities (ARE) and Boston Properties (BXP). American Assets Trust has seen five insider buy transactions and four insider sell transactions this year. American Assets Trust has a dividend yield of 2.78%. Alexandria Real Estate Equities has seen 14 insider sell transactions this year. Alexandria Real Estate Equities has a dividend yield of 4.10%. Boston Properties has seen one insider buy transaction and four insider sell transactions this year. Boston Properties has a dividend yield of 2.43%.

Top 10 Managed Healthcare Companies To Invest In Right Now: Universal Health Realty Income Trust (UHT)

Universal Health Realty Income Trust (Trust) is a real estate investment trust (REIT). It invests in health care and human service related facilities, including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings (MOBs). As of February 29, 2012, it had 54 real estate investments or commitments located in 15 states in the United States consisting of seven hospital facilities, including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute; 43 MOBs, and four preschool and childcare centers. In February, 2012, Canyon Healthcare Properties, in which it owned a 95% non-controlling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. In January, 2012, it purchased the PeaceHealth Medical Clinic, a single-tenant medical office building consisting of approximately 99,000 rentable square feet, located in Bellin gham, Washington. During the year ended December 31, 2011, the Company acquired Lake Pointe Medical Arts Building, Forney Medical Plaza, Tuscan Professional Building and Emory at Dunwoody Building, and minority ownership interests held by third-party members in 11 limited liability companies (LLCs). On November 30, 2011 and December 16, 2011, eight LLCs in which it owned various non-controlling, ownership interests, completed the divestitures of medical office buildings and related real property.

As of February 29, 2012, the Company had investments in 54 facilities, located in 15 states and consisting of Southwest Healthcare System, Inland Valley Campus, McAllen Medical Center, Wellington Regional Medical Center, The Bridgeway, Kindred Hospital Chicago Central, Kindred Hospital Corpus Christi, HealthSouth Deaconess Rehabilitation Hospital, Family Doctor’s Medical Office Bldg., Kelsey-Seybold Clinic at Kings Crossing, Professional Bldgs. at Kings Crossing Buil ding A and Building B, Chesterbrook Academy, Southern Cresce! nt Center I, Desert Valley Medical Center, Desert Springs Medical Plaza, and Santa Fe Professional Plaza. As of December 31, 2011, included in its portfolio are seven hospital facilities. During 2011, the leases with respect to these hospital facilities consisted approximately 65% of its revenue. As of December 31, 2011, these leases have fixed terms with an average of 4.4 years remaining and include renewal options ranging from one to five, five-year terms. During 2011, revenues generated from the leases on the Universal Health Services, Inc. (UHS) hospital facilities accounted for approximately 55% of its total revenue. During 2011, it had a total of 41 new or renewed leases related to the medical office buildings.

Advisors’ Opinion:

  • [By Dividends4Life]

    Related Articles:
    – Universal HealthRealty Income Trust (UHT) Dividend Stock Analysis
    – Hasbro, Inc. (HAS) Dividend Stock Analysis
    – W.W. Grainger, Inc. (GWW) Dividend Stock Analysis
    – The Clorox Company (CLX) Dividend Stock Analysis
    – More Stock Analysis

  • [By Dividends4Life]

    Linked here is a detailed quantitative analysis of Universal HealthRealty Income Trust (UHT). Below are some highlights from the above linked analysis:

Top 10 Managed Healthcare Companies To Invest In Right Now: Monsanto Co (MON)

Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a provider of agricultural products for farmers. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity. In April 2010, the Company completed the acquisition of a corn and soybean processing plant located in Paine, Chile from Anasac, a company that provides seed processing services. In October 2009, the Company completed the acquisition of Seminium, S.A. (Seminium), a corn seed company. In February 2011, the Company acquired Divergence, Inc. In September 2011, the Company acquired Beeologics. In June 2012, the Company purchased a planting technology developer, Precision Planting, Inc. In January 2013, it purchased select assets of Agradis, Inc. In June 2013, Monsanto Company acquired GrassRoots Biotechnology Inc. In November 2013, the Company announced that it has completed the acquisition of The Climate Corporation.

Seeds and Genomics Segment

Through the Company’s Seeds and Genomics segment, it produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed companies with genetic material and biotechnology traits for their seed brands. It has a global distribution and sales and marketing organization for its seeds and traits. It sells products under Monsanto brands and license technology and genetic material to others for sale under their own brands. Through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, it markets DEKALB, Asgrow and Deltapine branded germplasm to farmers globally. In the United States, it markets regional seed brands under it! s American Seeds, LLC and Channel Bio, LLC businesses to farmers directly, as well as through dealers, agricultural cooperatives and agents. It markets and sells trait technologies with branded germplasm, pursuant to license agreements with its farmer customers. In Brazil and Paraguay, its has implemented a point-of-delivery, grain-based payment system. It contracts with grain handlers to collect applicable trait fees when farmers deliver their grain. In addition to selling its products under its own brands, the Company licenses a range of germplasm and trait technologies to large and small seed companies in the United States and certain international markets. Those seed companies in turn market its trait technologies in their branded germplasm; they may also market its germplasm under its own brand name. Its vegetable seeds are marketed in more than 100 countries through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers and agents, as well as directly to farmers.

The Company’s row crop seeds brands include DEKALB, Channel Bio, Asgrow and Deltapine. Its DEKALB and Channel Bio are corn hybrids and foundation seed. Its Asgrow are soybean varieties and foundation seed. Its Deltapine are cotton varieties, hybrids and foundation seed. Canola is its row crop variety and hybrid. Its vegetable seed brands are Seminis and De Ruiter. These are open field and protected-culture seed for tomato, pepper, eggplant, melon, cucumber, pumpkin, squash, beans, broccoli, onions, and lettuce, among others. Its Biotechnology traits include SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, VT Double PRO, Roundup Ready and Roundup Ready 2 Yield and Genuity. Its SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO and VT Double PRO have applications for corn, and Bollgard and Bollgard II have application for cotton. It enables crops to protect themselves from borers and rootworm in corn and leaf- and bol l-feeding worms in cotton, reducing the need for application! s of inse! cticides. Its Roundup Ready and Roundup Ready 2 Yield have application for soybeans. The Company’s Genuity is a global umbrella trait brand. It enables crops, such as corn, soybeans, cotton, and canola to be tolerant of Roundup and other glyphosate-based herbicides. Monsanto also offers farmers stacked-trait products, which are single-seed products in which two or more traits are combined.

Agricultural Productivity Segment

Through the Company’s Agricultural Productivity segment, it manufactures Roundup brand herbicides and other herbicides and provide lawn-and-garden herbicide products for the residential market. Its products include Glyphosate-based herbicides, Selective herbicides and Lawn-and-garden herbicides. Its Glyphosate-based herbicides have applications in nonselective agricultural, industrial, ornamental and turf applications for weed control. Its Selective herbicides control preemergent annual grass and small seeded broadleaf weeds in corn and other crops. Its residential lawn-and-garden has applications for weed control. It uses the same distribution and sales and marketing organization for its crop protection products as for its seeds and traits. It also has separate distribution and sales and marketing organizations for its crop protection products. It sells crop protection products through distributors, independent retailers and dealers and agricultural cooperatives. In some cases outside the United States, it sells such products directly to farmers. It also sells certain of the chemical intermediates of its crop protection products to other agricultural chemical producers, who then market their own branded products to farmers. The Company markets its lawn-and-garden herbicide products through The Scotts Miracle-Gro Company.

Advisors’ Opinion:


    Sebastian Remme/Alamy Live News WASHINGTON — Genetically modified foods have been around for years, but most Americans have no idea if they are eating them. The Food and Drug Administration says they don’t need to be labeled, so the state of Vermont has moved forward on its own. On Thursday, Gov. Peter Shumlin signed legislation making his state the first to require labeling of genetically modified organisms, or GMOs. What about the rest of the country? And does labeling matter? There’s a lot of confusion about genetically modified foods and their safety. Some people feel very strongly about GMOs. Opponents, who at times have protested in the streets, say consumers have the right to know whether their food contains GMOs. The Vermont law is their first major victory. The food industry and companies that genetically engineer seeds have pushed back against the labeling laws, saying GMOs are safe and labels would be misleading. “It’s really polarizing,” says New York University’s Marion Nestle, a professor of nutrition and food studies. “There’s no middle ground.” A look at the debate and some of the facts about genetically modified foods: What They Are GMOs aren’t really a “thing,” Nestle says, and that’s hard for the average consumer to grasp. You can’t touch or feel a GMO. Genetically modified foods are plants or animals that have had genes copied from other plants or animals inserted into their DNA. It’s not a new idea — humans have been tinkering with genes for centuries through selective breeding. Think dogs bred to be more docile pets, cattle bred to be beefier or tomatoes bred to be sweeter. Turkeys were bred to have bigger breasts — better for Thanksgiving dinner. What’s different about genetically modified or engineered foods is that the manipulation is done in a lab. Engineers don’t need to wait for nature to produce a desired gene; they speed up the process by transferring a gene from one plant or animal to another. What are the desired

  • [By Dividends4Life]

    Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number MSFT is trading at a premium to all four valuations above. The stock is trading at a 41.4% discount to its calculated fair value of $68.12. MSFT earned a Star in this section since it is trading at a fair value.Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% MSFT earned three Stars in this section for 1.), 2.) and 3.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. MSFT earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 2003 and has increased its dividend payments for 12 consecutive years.Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA MSFT earned a Star in this section for its NPV MMA Diff. of the $14,663. This amount is in excess of the $2,300 target I look for in a stock that has increased dividends as long as MSFT has. If MSFT grows its dividend at 17.5% per year, it will take 2 years to

Top 10 Managed Healthcare Companies To Invest In Right Now: STERIS Corporation(STE)

STERIS Corporation and its subsidiaries develop, manufacture, and sell infection prevention, contamination control, microbial reduction, and surgical support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. It provides steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers; liquid chemical sterilant processing systems; washer/disinfector systems; general and specialty surgical tables; surgical and examination lights; equipment management systems; operating room storage cabinets; warming cabinets; scrub sinks; and other products and accessories. The company also offers connectivity solutions, such as operating room integration, workflow, patient tracking, and instrument management that allow transfer of information and images; cleaning chemistries and sterility assurance products; cleansing products, including hard surface disinfectants, and skin care and hand hygiene solutions; high-pu rity water equipment; vaporized hydrogen peroxide generators. In addition, it sells contract materials processing services using gamma irradiation and ethylene oxide technologies, as well as offers microbial reduction services based on customer specifications. Further, the company provides maintenance programs and repair services, sterilization and surgical management consulting services, information management and decision support services, and other support services, such as construction and facility planning, engineering support, device testing, customer education, hand hygiene process excellence, asset management/planning, and the sale of replacement parts. STERIS Corporation sells its products to end users, dealers, and distributors through direct field sales and service representatives. The company was formerly known as Innovative Medical Technologies and changed its name to STERIS Corporation in 1987. STERIS Corporation was founded in 1985 and is headquartered in Men t or, Ohio.

Advisors’ Opinion:

  • [By Sean Williams]

    What: Shares of Steris (NYSE: STE  )  — a manufacturer of infection prevention, contamination control, and surgical support products for the health-care industry — jumped as much as 10% after reporting better-than-expected fourth-quarter results.

Top 10 Managed Healthcare Companies To Invest In Right Now: CME Group Inc.(CME)

CME Group Inc. operates the CME, CBOT, NYMEX, and COMEX regulatory exchanges worldwide. The company provides a range of products available across various asset classes, including futures and options on interest rates, equity indexes, energy, agricultural commodities, metals, foreign exchange, weather, and real estate. It offers various products that provide a means of hedging, speculation, and asset allocation relating to the risks associated with interest rate sensitive instruments, equity ownership, changes in the value of foreign currency, credit risk, and changes in the prices of commodities. CME Group owns and operates clearing house, CME Clearing, which provides clearing and settlement services for exchange-traded contracts and counter derivatives transactions; and also engages in real estate operations. Its primary trade execution facilities consist of its CME Globex electronic trading platform and open outcry trading floors, as well as privately negotiated transact ions that are cleared and settled through its clearing house. In addition, the company offers market data services comprising live quotes, delayed quotes, market reports, and historical data services, as well as involves in index services business. CME Group?s customer base includes professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, and governments. It has strategic partnerships with BM&FBOVESPA S.A., Bursa Malaysia Derivatives, Singapore Exchange Limited, Green Exchange, Dubai Mercantile Exchange, Johannesburg Stock Exchange, and Bolsa Mexicana de Valores, S.A.B. de C.V., as well as joint venture agreement with Dow Jones & Company. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group was founded in 1898 and is headquartered in Chicago, Illinois.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Nasdaq OMX Group (NDAQ) have dropped 3% to $35.84 at 2:42 p.m. today, while IntercontinentalExchange (ICE) has fallen 2.1% to $193.69 and CME Group (CME) is off 2% at $72.53.

  • [By Lee Jackson]

    CME Group Inc. (NASDAQ: CME) exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options. CME Group brings buyers and sellers together through its Globex electronic trading platform and its trading facilities in New York and Chicago. The company also operates CME clearing, one of the world’s leading central counterparty clearing providers, which offers clearing and settlement services across asset classes for exchange-traded contracts and over-the-counter derivatives transactions. Investors are paid a solid 2.5% dividend. The consensus price target is $81.54. CME closed Wednesday at $75.71.

Top 10 Managed Healthcare Companies To Invest In Right Now: PFSweb Inc.(PFSW)

PFSweb, Inc. provides business process outsourcing and ecommerce solutions in the United States, Canada, and Europe. It offers digital marketing services comprising search engine optimization, pay-per-click, affiliate marketing, comparison shopping engines, merchandising, Web analytics, customer experience, email marketing, and social media; and ecommerce technology services, including End2End eCommerce solution for the direct-to-consumer (DTC) and business-to-business (B2B) online channels. The company also provides order management services consisting of order management interfaces, collaboration technologies, and information management services; customer care services, including customer relationship management, customer order assistance, quality monitoring, and interactive voice response; and logistics and fulfillment services comprising distribution facilities and infrastructure, facility operations and management, kitting and assembly, and product management and insp ection. In addition, it offers financial management services consisting of billing, credit, collection, and cash application services for B2B clients, as well as fraud review, chargeback management, and processing and settlement credit card services for DTC clients; and professional consulting services in the areas of interactive marketing ecommerce, supply chain management, distribution and fulfillment, technology interfacing, logistics, and customer support. Further, the company provides seller services financial models, including enablement financial, agent or flash financial, and retail financial models. It serves fashion apparel and accessories, fragrance and beauty products, consumer packaged goods, home furnishings and housewares, consumer electronics, office technology and network connectivity products, and aviation spare parts industries. The company was founded in 1999 and is headquartered in Allen, Texas.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    Technology stocks gained Thursday, with Infinera (NASDAQ: INFN) leading advancers. Meanwhile, gainers in the sector included LiveDeal (NASDAQ: LIVE), with shares up 5.5 percent, and PFSweb (NASDAQ: PFSW), with shares up 5.4 percent.

Top 10 Managed Healthcare Companies To Invest In Right Now: Charles River Laboratories International Inc. (CRL)

Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. The company offers a portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Its portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing customized approaches to support both single-study or broad-based programs. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Advisors’ Opinion:

  • [By Damian Illia]

    Based in Valencia, Calif., and founded in 1991, MannKind Corporation (MNKD) is a development stage biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapeutic products for diseases like diabetes. The company’s lead and only late stage pipeline candidate for this year is Afrezza, an inhalation powder which is an ultra insulin therapy for the treatment of adults with type 1 or type 2 diabetes to control their hyperglycemia. Currently, it is in late-stage clinical trials and a final decision from the U.S. regulatory body is expected by April 15, 2014. There is great concern revolving around this decision, as MannKind has already received two complete response letters (CRL) for Afrezza from the FDA, and it was requested to conduct two phase III trials with the next-generation inhaler. Further delay in approval or another setback related to this candidate could be a great danger for the company. Over and probably excessive depende nce on Afrezza — as the company discontinued any other reasearch in other candidates — is something to worry about. The company has generated no revenue last year round and its shares have experienced a total annual loss of $0.64 so far.